ProQR

ProQR Therapeutics NV (NASDAQ: PRQR) is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded in 2012 by chief executive officer (CEO) Daniel A. de Boer. It specializes in the development of RNA therapeutics using its RNA editing platform technology called Axiomer.

In the Vinony graph

Vinony's link graph records 3 inbound references to ProQR, and connects out to United States dollar, Leiden and Cambridge.

It is catalogued under topics including 2012 establishments in the Netherlands, Biotechnology companies established in 2012 and Biotechnology companies of the Netherlands.

Vinony links it to 5 Wikipedia language editions.

Official website

proqr.com →

Link to the official site · not written by Vinony

Wikidata facts

Instance of: business
Official website: www.proqr.com

Show 1 more fact

inception: 2012-00-00

Sources (2)

via Wikidata · CC0

~8 min read

Encyclopedic overview

5 sections

Contents

History
Projects
See also
References
External links

To offer you the best possible service, this site uses functional cookies as well as cookies for web statistics and videos. By clicking "Allow cookies" or continuing to use this website you give us consent to use cookies.

Allow cookies

Excerpted from Wikipedia’s “ProQR” article, available under the CC BY-SA 4.0 licence.